Chairman and CEO Jennifer Parmentier said it was the first quarter with double-digitOrganic Salesgrowth in more than three years. Adjusted segment operating margin expanded 120 basis points to a record 28.6%.
• PBGENE-HBV achieved pgRNA loss to undetectable in 100% of evaluable patients at the 0.4 mg/kg dose.
Net income attributable to common stockholders was USD 12.2 million versus USD 27.6 million in the prior-year quarter, and USD 31.8 million for nine months versus USD 46.7 million.
The increase in cash was due to a USD 100 million milestone payment received from AbbVie in July 2026 for the dosing of the first patient in the Phase IIb/III NAAVIGATE study, and net proceeds of USD 108 million from an underwritten public offering …
President and CEO Patrice Louvet said results exceeded expectations on both the top and bottom line, which allowed the company to raise its full year guidance once again. Total company revenue grew 10%, driven by better-than-expected performance in both direct-to-consumer and wholesale channels. Total …
Chairman and CEO Blake Moret said the company delivered broad-based topline growth,Marginexpansion and double-digitEarningsgrowth. Excluding the tariff refunds and the Sensia joint venture dissolution, core sales grew 7% in the quarter.
For the nine months ended September 30, 2026, net sales were USD 6,165 million, with organic growth of 2.9% and reported growth of negative 2.6%.
Chief Executive Officer Eli Simon said leasing momentum continued, rents and occupancy increased, and shopper traffic growth accelerated for the third consecutive quarter, driving robust retailer sales growth. The company increased its full-year 2026 Real Estate FFO per share guidance and raised its quarterly …
Chairman and CEO Jeffrey Martin said that based on the strength of financial performance the company guides to the high end of its 2026 adjusted EPS guidance range and affirms its 2027 range. Third quarterGAAPEarningswere USD 877 million, and adjusted earnings were up 26% …
Loss from operations was USD 199.0 million versus income from operations of USD 32.5 million a year earlier. Loss before income taxes was USD 200.5 million versus income of USD 31.4 million.